Zura Bio Limited
ZURA
$5.78
-$0.36-5.79%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -9.30% | 1.02% | 7.72% | 14.18% | 79.42% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 28.17% | 23.35% | 36.34% | 44.31% | 75.85% |
| Operating Income | -28.17% | -23.35% | -36.34% | -44.31% | -75.85% |
| Income Before Tax | -26.65% | -21.47% | -31.00% | -37.77% | -94.61% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -26.53% | -21.47% | -31.00% | -37.77% | -94.61% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -26.53% | -21.47% | -31.00% | -37.77% | -94.61% |
| EBIT | -28.17% | -23.35% | -36.34% | -44.31% | -75.85% |
| EBITDA | -28.13% | -23.30% | -60.67% | -133.40% | -515.21% |
| EPS Basic | -55.55% | -50.42% | -92.57% | -15.14% | -45.51% |
| Normalized Basic EPS | -6.95% | -6.34% | -5.73% | 3.09% | -12.81% |
| EPS Diluted | -55.55% | -50.42% | -92.57% | -15.14% | -45.51% |
| Normalized Diluted EPS | -6.95% | -6.34% | -5.73% | 3.09% | -12.81% |
| Average Basic Shares Outstanding | 17.20% | 14.36% | 25.48% | 45.47% | 69.40% |
| Average Diluted Shares Outstanding | 17.20% | 14.36% | 25.48% | 45.47% | 69.40% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |